tender for supply of medicines as per attached boq , inj aflibercept 40 mg/ml with sterile syringe and 30g needle, (for opthalmic use) , injection, benralizumab prefilled pen of 30mg/ml , injection,aspart insulin,human insulin analogue injection (biosynthesis r-dna origin) soluble insulin aspart 100 iu/ml in 3ml cartridge, (one compatible pen shall be provided behind every 30 cartridges) , glulysine 100/ml inj cartridge of 3 ml(one compatiable pen shall beprovided behind every 30 cartridges) , dexamethasone intravitreal implant 0.7 mg (in solid polymer drug delivery system) , injection,pneumoccocal polysaccharide vaccine 0.5ml, each 0.5ml single dose of vaccine contains 25mcg polysaccharide of each of 23 pneumococcal serolypes and phenol as a preservative 0.25% w/v cy im.5% sodium chloride 0.9% w/v water for inj q.s, total amount of polysaccharide per vial = 862.5mcg/0.75ml , injection, secukinumab, 150 mg , tablet, vericiguat, 5 mg , tab. canagliflozin 100mg , injection tocilizumab 80 mg , injection, goserline acetate 3.6mg , injection,infliximab,100 mg , capsule, isavuconazole, 100 mg , inj liraglutide 6 mg / ml , injection, paliperidone palmitate 100 mg , inj, paliperidone palmitate 150 mg , injection, ranibizumab 10 mg/ml, containing 0.16 ml solution for opthalmic use with sterile 30g needle